InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Discover the complete record of transactions filed by Serber Zachariah, Directeur Scientifique. Insider active across 1 company, notably Zymergen Inc.. In total, 12 reports have been published. Split: 0 buy · 11 sells. Total volume traded: €320k. Activity tracked since 24 January 2022. The latest transaction was filed on 2 June 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations12 total
2,812 shares@ US$1.67761.4% of flowCommon StockSEC:0001645842-22-000098:0
3,082 shares@ US$1.79031.6% of flowCommon StockSEC:0001645842-22-000063:0
208,000 shares0Common StockSEC:0001645842-22-000034:0
4,011 shares@ US$3.91134.4% of flowCommon StockSEC:0001645842-22-000023:0
1,424 shares@ US$3.911.5% of flowCommon StockSEC:0001645842-22-000021:0
5,435 shares@ US$3.99816.0% of flowCommon StockSEC:0001645842-22-000017:0
5,435 shares@ US$4.32916.4% of flowCommon StockSEC:0001645842-22-000015:0
5,435 shares@ US$4.329115.1% of flowCommon StockSEC:0001645842-22-000015
5,435 shares@ US$5.03397.7% of flowCommon StockSEC:0001645842-22-000011:0
5,435 shares@ US$5.033918.0% of flowCommon StockSEC:0001645842-22-000011
21,730 shares@ US$4.760528.5% of flowCommon StockSEC:0001645842-22-000009:0
21,730 shares@ US$4.760566.9% of flowCommon StockSEC:0001645842-22-000009
12 of 12 declarations
About Serber Zachariah
Zachariah Serber is the Chief Science Officer at Zymergen Inc. In this role, he oversees the company's research and development initiatives, which focus on innovation in biotechnology. With expertise in the sciences, he plays a crucial role in the research strategy of Zymergen Inc.
